Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1291 studies found for:    "Squamous cell carcinoma"
Show Display Options
Rank Status Study
21 Completed Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer
Condition: Squamous Cell Cancer
Intervention: Drug: proflavine
22 Completed
Has Results
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Cancer
Interventions: Drug: Imatinib Mesylate;   Drug: Docetaxel
23 Recruiting Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
Conditions: Carcinoma, Squamous Cell of Head and Neck;   HPV Positive Oropharyngeal Squamous Cell Carcinoma;   Hypopharyngeal Cancer;   Early Invasive Cervical Squamous Cell Carcinoma;   Carcinoma of Larynx;   Cancer of Nasopharynx
Interventions: Drug: BKM120;   Drug: Cisplatin;   Radiation: Intensity-modulated radiotherapy (IMRT)
24 Completed Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Conditions: Head and Neck Cancer;   Oropharyngeal Cancer;   Human Papillomavirus;   Squamous Cell Cancer
Intervention:
25 Withdrawn A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck
Conditions: Head and Neck Neoplasms;   Squamous Cell Cancer
Intervention: Procedure: Intensity Modulated Radiotherapy
26 Not yet recruiting Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity
Conditions: Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Radiation: hypofractionated radiation therapy;   Radiation: intensity-modulated radiation therapy;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
27 Not yet recruiting Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer
Condition: Skin Squamous Cell Cancer
Intervention: Drug: Dacomitinib
28 Recruiting A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Conditions: Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC) Patients Who Are Resistant or Ineligible/Intolerant to Platinum-based Chemotherapy.;   Recurrent Head and Neck Squamous Cell Carcinoma;   Metastatic Head and Neck Squamous Cell Carcinoma
Interventions: Drug: BYL719 as film-coated (FC) whole tablets;   Drug: BYL719 as dispersible tablets (DT);   Biological: cetuximab;   Drug: BYL719 as film-coated (FC) drink suspension
29 Recruiting Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer
Condition: Esophageal Squamous Cell Cancer
Interventions: Drug: Cisplatin, 5-FU;   Drug: Panitumumab
30 Recruiting Study of HPV Specific Immunotherapy in Patients With HPV Associated Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Cancer
Intervention: Biological: 1.1 mL of VGX-3100 and INO-9012 delivered via IM EP
31 Terminated Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
Condition: Squamous Cell Cancer of the Head and Neck
Interventions: Radiation: Radiation;   Drug: Cetuximab
32 Completed Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip
Conditions: Actinic Cheilitis;   Squamous Cell Carcinoma In-situ (SCC-is);   Squamous Cell Carcinoma (SCC);   Photodynamic Therapy (PDT);   Mohs Surgery
Intervention: Procedure: PDT prior to Mohs surgery
33 Recruiting Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma
Condition: Esophageal Squamous Carcinoma
Interventions: Drug: Paclitaxel;   Drug: Erlotinib;   Radiation: Radiation therapy
34 Not yet recruiting Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Conditions: Cancer of Head and Neck;   Head and Neck Cancer;   Neoplasms, Head and Neck;   Carcinoma, Squamous Cell of Head and Neck;   Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma, Head and Neck
Interventions: Biological: MK-3475;   Procedure: Surgery;   Radiation: Intensity modulated radiation therapy;   Radiation: Image-guided radiation therapy;   Drug: Cisplatin
35 Recruiting Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma
Conditions: Oral Cavity Squamous Cell Carcinoma;   Oropharyngeal Squamous Cell Carcinoma
Intervention:
36 Not yet recruiting Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Intervention:
37 Completed Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
Conditions: Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck;   Neoplasms, Head and Neck
Intervention: Drug: GSK1363089 (foretinib)
38 Completed
Has Results
Warning Signs of Squamous Cell Carcinoma and Prevention of SCC by at Risk Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Interventions: Behavioral: Educational Intervention;   Behavioral: Placebo
39 Completed Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Condition: Squamous Cell Carcinoma
Intervention: Drug: Erlotinib
40 Recruiting Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Conditions: Salivary Gland Squamous Cell Carcinoma;   Stage II Salivary Gland Cancer;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Verrucous Carcinoma of the Oral Cavity
Interventions: Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Radiation: image-guided adaptive radiation therapy;   Other: 3'-deoxy-3'-[18F]fluorothymidine;   Procedure: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years